首页|ADH1B与ALDH2在胃癌组织中的表达及其临床意义

ADH1B与ALDH2在胃癌组织中的表达及其临床意义

扫码查看
目的 探讨乙醇脱氢酶 1B(alcohol dehydrogenase 1B,ADH1B)与乙醛脱氢酶 2(aldehyde dehydrogenase 2,ALDH2)在胃癌组织中的表达及其临床意义.方法 选取2017年05月至2019年10月期间在滁州市第一人民医院接受根治性切除的132例胃癌患者为研究对象,通过免疫组织化学染色(Immunohistochemistry,IHC)检测ADH1B与ALDH2在胃癌及癌旁组织中的表达.分析ADH1B、ALDH2表达与患者临床病理特征的关系,采用Kaplan-Meier曲线评估两者表达在胃癌中的预后价值.单、多变量Cox回归分析用于确定胃癌患者的独立预后因素.结果 对132例组织样本的IHC分析显示ADH1B(41.5%vs 58.5%,x2=9.594,P=0.002)与 ALDH2(38.8%vs 61.2%,x2=16.716,P<0.001)在胃癌组织中的阳性表达率显著低于其癌旁组织.与高表达组相比,ADH1B低表达在T3-T4期(x2=5.572,P=0.018)、pTNM Ⅲ期肿瘤(x2=4.675,P=0.031)中更为常见,淋巴血管侵犯率更高(x2=4.566,P=0.033).ALDH2在低分化癌(x2=4.261,P=0.039)和pTNM Ⅲ期胃癌(x2=5.877,P=0.015)中表达更低,淋巴结转移率(x2=5.491,P=0.019)较高表达者更为频繁.生存分析表明ADH1B与ALDH2低表达是胃癌患者预后不良的标志.ADH1B低、高表达患者的3年总体生存(Overall survival,OS)率分别为52.3%和73.9%(x2=6.900,P=0.009),ALDH2 低、高表达患者的 3 年 OS 率分别为 49.8%和 74.4%(x2=8.665,P=0.003).ADH1B(HR=2.115,95%CI:1.133-3.946,P=0.019)与 ALDH2 低表达(HR=2.296,95%CI:1.207-4.367,P=0.011)是胃癌患者的独立预后因素.结论 ADH1B与ALDH2在胃癌组织中呈明显低表达,两者可能是预测肿瘤进展与患者预后的分子标志物.
The expression and clinical significance of ADH1B and ALDH2 in gastric cancer
Objective To investigate the expression of alcohol dehydrogenase 1B(ADH1B)and aldehyde dehydrogenase 2(ALDH2)and their clinical significance in gastric cancer patient.Methods Totally,132 gastric cancer patients who underwent curative resection in Chuzhou First People's Hospital from May 2017 to October 2019 were included.The expression of ADH1B and ALDH2 in gastric cancer and adjacent non-cancer tissues were detected by immunohistochemistry(IHC).The relationships between the expression of ADH1 B and ALDH2 and clinicopathologic characteristics were analyzed,and their prognostic value for gastric cancer patients were evaluated using Kaplan-Meier curves.Univariate and multivariate Cox regression analysis were conducted to determine independent prognostic factors for gastric cancer patients.Results The IHC analysis of 132 tissue samples showed that the positive rates of ADH1B(41.5%vs 58.5%,x2=9.594,P=0.002)and ALDH2 expression(38.8%vs 61.2%,x2=16.716,P<0.001)in gastric cancer tissues were significantly lower than in adjacent non-cancer tissues.Compared with high expression group,low expression of ADH1B was frequently detected in T3-T4 stage(x2=5.572,P=0.018)and pTNM stage Ⅲ(x2=4.675,P=0.031)and had a higher rate of lymphovascular invasion(x2=4.566,P=0.033).Also,low expression of ALDH2 was frequently detected in poorly-differentiated adenocarcinoma(x2=4.261,P=0.039)and pTNM stage Ⅲ(x2=5.877,P=0.015),and had a higher incidence of lymph node metastasis(x 2=5.491,P=0.019)than its high expression.Survival analysis indicated that low expression of ADH1B and ALDH2 were associated with poor prognosis of gastric cancer patients.The 3-year overall survival(OS)rates of patients with low and high expression of ADH1B were 52.3%and 73.9%,respectively(x2=6.900,P=0.009).The 3-year OS rates of patients with low and high expression of ALDH2 were 49.8%and 74.4%,respectively(x 2=8.665,P=0.003).The expression of ADH1B(HR=2.115,95%CI:1.133-3.946,P=0.019)and ALDH2(HR=2.296,95%CI:1.207-4.367,P=0.011)were identified as independent prognostic factors for gastric cancer patients.Conclusion The expression of ADH1B and ALDH2 were decreased in gastric cancer tissues,and they might be useful biomarkers for predicting tumor progression and survival outcome.

Gastric canceralcohol dehydrogenase 1B(ADH1B)aldehyde dehydrogenase 2(ALDH2)immunohistochemistry(IHC)prognostic

贾云兰、周仁正、池堂春

展开 >

239004 滁州市第一人民医院病理科

239004 滁州市第一人民医院消化内科

胃癌 乙醇脱氢酶1B 乙醛脱氢酶2 免疫组织化学染色 预后

安徽省卫生健康科研项目

AHWJ2022b120

2024

现代消化及介入诊疗
广东省医学学术交流中心

现代消化及介入诊疗

CSTPCD
影响因子:1.019
ISSN:1672-2159
年,卷(期):2024.29(3)